Atlas Trials

Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects

Clinical trial NCT01216046 · COMPLETED

Trial details

NCT number
NCT01216046
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2010-10-01
Primary completion
2011-05-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.